ALLIANCEBERNSTEIN L.P. - DENALI THERAPEUTICS INC ownership

DENALI THERAPEUTICS INC's ticker is DNLI and the CUSIP is 24823R105. A total of 173 filers reported holding DENALI THERAPEUTICS INC in Q3 2020. The put-call ratio across all filers is 1.34 and the average weighting 0.6%.

Quarter-by-quarter ownership
ALLIANCEBERNSTEIN L.P. ownership history of DENALI THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$2,821,359
-46.5%
136,760
-23.5%
0.00%
-50.0%
Q2 2023$5,274,027
+34.5%
178,720
+5.0%
0.00%0.0%
Q1 2023$3,920,486
-9.0%
170,160
+9.8%
0.00%0.0%
Q4 2022$4,309,438
-9.4%
154,9600.0%0.00%0.0%
Q3 2022$4,756,000
+4.3%
154,9600.0%0.00%0.0%
Q2 2022$4,560,000
-8.5%
154,9600.0%0.00%0.0%
Q1 2022$4,985,000
-27.7%
154,960
+0.2%
0.00%0.0%
Q4 2021$6,898,000
-11.6%
154,6600.0%0.00%
-33.3%
Q3 2021$7,803,000
-36.0%
154,660
-0.5%
0.00%
-40.0%
Q2 2021$12,186,000
+120.9%
155,360
+60.8%
0.01%
+150.0%
Q1 2021$5,516,000
-31.3%
96,600
+0.7%
0.00%
-50.0%
Q4 2020$8,033,000
+140.6%
95,900
+2.9%
0.00%
+100.0%
Q3 2020$3,339,000
+44.7%
93,200
-2.3%
0.00%
+100.0%
Q2 2020$2,307,000
+84.6%
95,400
+33.6%
0.00%0.0%
Q1 2020$1,250,000
+1.1%
71,400
+0.6%
0.00%0.0%
Q4 2019$1,237,000
+13.7%
71,0000.0%0.00%0.0%
Q3 2019$1,088,000
-26.2%
71,0000.0%0.00%0.0%
Q2 2019$1,474,000
-8.5%
71,000
+2.3%
0.00%0.0%
Q1 2019$1,611,000
+12.3%
69,4000.0%0.00%0.0%
Q4 2018$1,434,000
+25.9%
69,400
+32.4%
0.00%0.0%
Q3 2018$1,139,000
+194.3%
52,400
+106.3%
0.00%
Q2 2018$387,00025,4000.00%
Other shareholders
DENALI THERAPEUTICS INC shareholders Q3 2020
NameSharesValueWeighting ↓
Crestline Management, LP 19,462,500$339,037,00035.95%
Euclidean Capital LLC 323,749$27,117,0005.74%
Flagship Pioneering Inc. 2,730,263$228,687,0004.16%
Casdin Capital, LLC 1,310,000$109,726,0003.25%
A.R.T. Advisors, LLC 6,173$517,0002.39%
MARK ASSET MANAGEMENT LP 172,040$14,410,0001.73%
Temasek Holdings (Private) Ltd 4,410,457$369,420,0001.59%
Integral Health Asset Management, LLC 57,500$4,816,0001.43%
GILDER GAGNON HOWE & CO LLC 3,219,843$269,694,0001.34%
IRONWOOD INVESTMENT MANAGEMENT LLC 19,365$1,622,0000.95%
View complete list of DENALI THERAPEUTICS INC shareholders